Announcement PDF Appendix 3Y Change of Director’s Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity: Elixinol Wellness Limited ABN: 621 479 794 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Helen Wiseman Date of last notice 13 June 2023 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct Nature of indirect interest (including registered holder) N/A Note: Provide details of the circumstances giving rise to the relevant interest. Date of change 31 August 2023 No. of securities held prior to change 835,688 Fully paid Ordinary Shares 1,043,424 Performance Share Rights 3,055,556 Director Fee rights 555,556 Unlisted Options Class 1) Fully paid ordinary shares 2) Unlisted options with an exercise price of $0.02 expiring on 31 August 2025 3) Director Fee rights Number acquired 1) 2) 3) + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 763,889 763,889 Nil Appendix 3Y Change of Director’s Interest Notice Number disposed 1) 2) 3) Value/Consideration Nil financial consideration vesting of Director Fee rights. Note: If consideration is non-cash, provide details and estimated valuation Nil Nil 763,889 paid on No. of securities held after change 1,599,577 Fully paid Ordinary Shares 1,043,424 Performance Share Rights 2,291,667 Director Fee rights 1,319,445 Unlisted Options Nature of change Issue of fully paid ordinary shares and unlisted options on vesting of Director Fee rights Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) N/A Date of change N/A No. and class of securities to which N/A interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired N/A Interest disposed N/A Value/Consideration N/A Note: If consideration is non-cash, provide details and an estimated valuation Interest after change N/A + See chapter 19 for defined terms. Appendix 3Y Page 2 01/01/2011 Appendix 3Y Change of Director’s Interest Notice Part 3 – +Closed period Were the interests in the securities or contracts detailed No above traded during a +closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade N/A to proceed during this period? If prior written clearance was provided, on what date was this N/A provided? + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3